secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biofrontera Inc. (BFRI)
CIK:        0001858685
Form:       8-K
Filed at:   2026-02-26T23:59:59+00:00
Accession:  0001493152-26-008136
Event type: litigation
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PTAB finds Sun Pharma’s patent '028 unpatentable, a win for Biofrontera in patent dispute
--------------------------------------------------------------------------------

- PTAB issued Final Written Decision on Feb 23, 2026, invalidating all challenged claims of Sun's U.S. Patent No. 11,697,028.
- Sun may request rehearing, petition the Director, or appeal to the Federal Circuit.
- Decision does not affect the separate '512 patent; that IPR petition was denied on administrative grounds.
- Impact on parallel District Court and ITC proceedings is not yet determinable.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858685/000149315226008136/0001493152-26-008136-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858685/000149315226008136/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-008136

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer